293 related articles for article (PubMed ID: 34878295)
1.
Yang J; Ma W; Wu Y; Zhou H; Song S; Cao Y; Wang C; Liu X; Ren J; Duan J; Pei Z; Jin C
Microbiol Spectr; 2021 Dec; 9(3):e0039921. PubMed ID: 34878295
[TBL] [Abstract][Full Text] [Related]
2. Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen.
Schwarz F; Landig CS; Siddiqui S; Secundino I; Olson J; Varki N; Nizet V; Varki A
EMBO J; 2017 Mar; 36(6):751-760. PubMed ID: 28100677
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation.
King MR; Vimr RP; Steenbergen SM; Spanjaard L; Plunkett G; Blattner FR; Vimr ER
J Bacteriol; 2007 Sep; 189(17):6447-56. PubMed ID: 17601779
[TBL] [Abstract][Full Text] [Related]
4. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
Colino J; Outschoorn I
Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
[TBL] [Abstract][Full Text] [Related]
5. Mobile contingency locus controlling Escherichia coli K1 polysialic acid capsule acetylation.
Vimr ER; Steenbergen SM
Mol Microbiol; 2006 May; 60(4):828-37. PubMed ID: 16677296
[TBL] [Abstract][Full Text] [Related]
6. The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells.
Kim KJ; Elliott SJ; Di Cello F; Stins MF; Kim KS
Cell Microbiol; 2003 Apr; 5(4):245-52. PubMed ID: 12675682
[TBL] [Abstract][Full Text] [Related]
7. Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus.
Deszo EL; Steenbergen SM; Freedberg DI; Vimr ER
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5564-9. PubMed ID: 15809431
[TBL] [Abstract][Full Text] [Related]
8. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
Roy S; Mandal C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-coenzyme A:polysialic acid O-acetyltransferase from K1-positive Escherichia coli. The enzyme responsible for the O-acetyl plus phenotype and for O-acetyl form variation.
Higa HH; Varki A
J Biol Chem; 1988 Jun; 263(18):8872-8. PubMed ID: 2897964
[TBL] [Abstract][Full Text] [Related]
10. Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide.
Orskov F; Orskov I; Sutton A; Schneerson R; Lin W; Egan W; Hoff GE; Robbins JB
J Exp Med; 1979 Mar; 149(3):669-85. PubMed ID: 372481
[TBL] [Abstract][Full Text] [Related]
11. Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1.
Zelmer A; Martin MJ; Gundogdu O; Birchenough G; Lever R; Wren BW; Luzio JP; Taylor PW
Microbiology (Reading); 2010 Jul; 156(Pt 7):2205-2215. PubMed ID: 20395269
[TBL] [Abstract][Full Text] [Related]
12. Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway.
Grabenstein S; Barnard KN; Anim M; Armoo A; Weichert WS; Bertozzi CR; Parrish CR; Willand-Charnley R
Glycobiology; 2021 Nov; 31(10):1279-1294. PubMed ID: 34192335
[TBL] [Abstract][Full Text] [Related]
13. Multifarious roles of sialic acids in immunity.
Varki A; Gagneux P
Ann N Y Acad Sci; 2012 Apr; 1253(1):16-36. PubMed ID: 22524423
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
Park IH; Lin J; Choi JE; Shin JS
Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
[TBL] [Abstract][Full Text] [Related]
15. Dual actions of group B
Uchiyama S; Sun J; Fukahori K; Ando N; Wu M; Schwarz F; Siddiqui SS; Varki A; Marth JD; Nizet V
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7465-7470. PubMed ID: 30910970
[TBL] [Abstract][Full Text] [Related]
16. Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression.
Metkar S; Awasthi S; Denamur E; Kim KS; Gangloff SC; Teichberg S; Haziot A; Silver J; Goyert SM
Infect Immun; 2007 Nov; 75(11):5415-24. PubMed ID: 17709409
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Group B Streptococcus sialylated capsular polysaccharides with host Siglec-like molecules dampens the inflammatory response in tilapia.
Dong J; Wei Y; Sun C; Tian Y; Hu J; Shi H; Zhang D; Lu M; Ye X
Mol Immunol; 2018 Nov; 103():182-190. PubMed ID: 30291999
[TBL] [Abstract][Full Text] [Related]
18. O-acetyltransferase gene neuO is segregated according to phylogenetic background and contributes to environmental desiccation resistance in Escherichia coli K1.
Mordhorst IL; Claus H; Ewers C; Lappann M; Schoen C; Elias J; Batzilla J; Dobrindt U; Wieler LH; Bergfeld AK; Mühlenhoff M; Vogel U
Environ Microbiol; 2009 Dec; 11(12):3154-65. PubMed ID: 19671077
[TBL] [Abstract][Full Text] [Related]
19. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.
Mushtaq N; Redpath MB; Luzio JP; Taylor PW
Antimicrob Agents Chemother; 2004 May; 48(5):1503-8. PubMed ID: 15105097
[TBL] [Abstract][Full Text] [Related]
20. Host factors in the resistance of newborn mice to K1 Escherichia coli infection.
Pluschke G; Pelkonen S
Microb Pathog; 1988 Feb; 4(2):93-102. PubMed ID: 3059139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]